Related Experiment Video
Updated: Jul 16, 2026

Assessing Cortical Cerebral Microinfarcts on High Resolution MR Images
Published on: November 20, 2015
Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia
E Kövari1, G Gold, F R Herrmann
1Department of Psychiatry, University of Geneva School of Medicine, Chêne-Bourg, Switzerland. eniko.kovari@hcuge.ch
Objective:
To investigate the possible synergistic effect of microvascular lesions with mild Alzheimer disease (AD) pathology in mixed cases.
Methods:
We assessed the cognitive impact of cortical microinfarcts, deep white matter and periventricular demyelination, as well as diffuse and focal gliosis in a large series of 43 prospectively evaluated autopsy cases scored Braak neurofibrillary tangle stage III, but without macroscopic vascular pathology or substantial non-AD, nonvascular microscopic lesions. We included bilateral assessment of all types of microvascular lesions and used multivariate models that control for the possible confounding effect of age and amyloid beta-protein (Abeta) deposits.
Results:
Only cortical microinfarcts and periventricular demyelination were significantly associated with the Clinical Dementia Rating Scale (CDR) score. In a univariate model, the cortical microinfarct score explained 9% of the variability in CDR scores and periventricular demyelination score 7.3%. Abeta deposition explained only 3.5% of the CDR variability. In a logistic regression model, both variables were strongly associated with the presence of dementia (R = 0.45; p < 0.05). When the CDR sum of the boxes was used, Abeta staging explained 8.9% of cognitive variability, the addition of cortical microinfarct predicted an extra 15.5%, and that of periventricular demyelination an extra 9%.
Conclusions:
Cortical microinfarcts and, to a lesser degree, periventricular demyelination contribute to the cognitive decline in individuals at high risk for dementia. Both should be taken into account when defining the neuropathologic criteria for mixed dementia.
Insights
Microvascular lesions, specifically cortical microinfarcts and periventricular demyelination, significantly contribute to cognitive decline in individuals at high risk for dementia. These findings are crucial for diagnosing mixed dementia.
Area of Science:
- Neuropathology
- Neurodegenerative Diseases
- Vascular Neurology
Background:
- Alzheimer disease (AD) pathology is often mixed with other pathologies, including microvascular lesions.
- Understanding the contribution of these mixed pathologies to cognitive decline is crucial for accurate diagnosis and treatment.
Purpose of the Study:
- To investigate the synergistic effect of microvascular lesions and mild Alzheimer disease pathology in mixed dementia cases.
- To assess the cognitive impact of specific microvascular lesions in individuals with early AD pathology.
Main Methods:
- Assessed cognitive impact of cortical microinfarcts, white matter demyelination, and gliosis in 43 autopsy cases with Braak stage III neurofibrillary tangles.
- Used multivariate models controlling for age and amyloid-beta (Abeta) deposits, with bilateral assessment of microvascular lesions.
Main Results:
- Cortical microinfarcts and periventricular demyelination were significantly associated with Clinical Dementia Rating (CDR) scores.
- Cortical microinfarcts explained 9% and periventricular demyelination 7.3% of CDR variability, while Abeta deposition explained only 3.5% in univariate models.
- In logistic regression, both microinfarcts and demyelination strongly predicted dementia presence (R=0.45, p<0.05); adding them to Abeta staging significantly increased cognitive variability prediction.
Conclusions:
- Cortical microinfarcts and periventricular demyelination contribute to cognitive decline in individuals at high risk for dementia.
- These vascular lesions should be considered in the neuropathologic criteria for mixed dementia.
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction
Dementia
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Development During Adulthood

